The Bangladesh Medical Research Council (BMRC) has approved Bangavax - Bangladesh's first homegrown vaccine, for human trials.
Bangavax was initially known as Bancovid.
The Daily Star reported that senior manager for quality and regulation at Directorate General of Drug Administration (DGDA) stated that the manufacturer of Bangavax, Globe Biotech is set to send DGDA human trial protocol.
Human trials will be initiated by Globe Biotech once the single-dose vaccine, Bangavax gets assent for clinical trials from DGDA, said DGDA senior manager.
Globe Biotech on October 5 the previous year, revealed that its first vaccine candidate had shown promise in pre-clinical trials on mice, reported the Daily Star.
0 Comments